About Aqualor
Aqualor, established in 2007 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of nasal drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarter Russia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aqualor
Detailed funding history for Aqualor
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aqualor
Aqualor has secured backing from 1 investor. Prominent investors backing the company include Stada.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of generics and biosimilars
|
Locked | Locked | Locked |
Investor details for Aqualor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aqualor
Investment portfolio details for Aqualor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aqualor
Detailed financials for Aqualor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aqualor Comparisons
Peer comparison for Aqualor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aqualor
Detailed competitors of Aqualor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aqualor
Complete news archive for Aqualor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aqualor
Aqualor was founded in 2007.
Aqualor is headquartered in Russia.
Peter Goldschmidt is the current CEO of Aqualor.
Aqualor, established in 2007 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of nasal drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Aqualor has 1 investor. Key investors include Stada.